DGCR8 is essential for tumor progression following PTEN loss in the prostate

Publisher: John Wiley & Sons Inc

E-ISSN: 1469-3178|16|9|1219-1232

ISSN: 1469-221x

Source: EMBO REPORTS, Vol.16, Iss.9, 2015-09, pp. : 1219-1232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract